Alcohol and insulin sensitivity

Netherlands Journal of Medicine

Volumn 52, Issue 3, 1998, Pages 91-94

  Van De Wiel, A ^a  

^a EEMLAND HOSPITAL   (Netherlands)

Author keywords

Alcohol; High density lipoprotein cholesterol; Insulin resistance; Insulin sensitivity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERINSULINISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY;

ALCOHOL DRINKING; BLOOD GLUCOSE; CORONARY DISEASE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, HDL;

EID: 0032033468     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00087-9     Document Type: Article

References (28)

1. Veenstra, J, Effects of alcohol on the cardiovascular system. In: Veenstra J, Van der Hey DG, editors. Alcohol and cardiovascular disease. Wageningen: Pudoc, 1992;87-113.
2. DeFronzo R.A. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth. J. Med. 50:1997;191-197.
3. Renaud S., De Lorgeril M. Wine, alcohol, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
4. Rimm E.B., Klatsky A., Grobbee D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? Br. Med. J. 312:1996;731-736.
5. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
6. Fuhrman B., Lavy A., Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61:1995;549-554.
7. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
8. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics transresveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta. 235:1995;207-219.
9. Van Golde P.H.M., Hart H.Ch., Van der Meijden B.B., Kraaijenhagen R.J., Bouma B.N., Van de Wiel A. Aggregation of platelets is inhibited in vitro by red wine as well as its alcohol-deprived equivalent; ethanol is not a necessary component. Neth. J. Med. 50:1997;A28-A29.
10. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease; the Zutphen elderly study. Lancet. 342:1993;1007-1011.
11. Välimäki M, Taskinen MR, Effect of different doses of alcohol on serum lipoproteins. In: Veenstra J, Van der Hey DG, editors. Alcohol and the cardiovascular system. Wageningen: Pudoc, 1992;75-86.
12. Langer R.D., Criqui M.H., Reed D.M. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 85:1992;910-915.
13. Suh I., Shaten J., Cutler J.A., Kuller L.H. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann. Int. Med. 116:1992;881-887.
14. Savalainen M.J., Hannuksela M., Seppänen S., Kervinen K., Kosäniemi Y.A. Increased high-density lipoprotein cholesterol in alcoholics is related to decreased activity of cholesteryl transfer protein. Eur. J. Clin. Invest. 20:1990;593-599.
15. Laws A., Reaven G.M. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride, and insulin concentration. J. Intern. Med. 231:1992;25-30.
16. Reaven G.M. Syndrome X: 6 years later. J. Intern. Med. 236:1994;13-22.
17. Després J.P., Lamarche B., Mauriège P., Cantin B., Dagenais G.R., Moorjani S., Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:1996;952-957.
18. Yki-Järvinen H., Nikkilä E.A. Ethanol decreases glucose utilization in healthy men. J. Clin. Endocrinol. Metab. 61:1985;941-945.
19. Shelmet J.J., Reichard G.A., Skutches C.L., Hoeldtke R.D., Owen O.E., Boden G. Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J. Clin. Invest. 81:1988;1137-1145.
20. Razay G., Heaton K.W., Bolton C.H., Hughes A.O. Alcohol consumption and its relation to cardiovascular risk factors in British women. Br. Med. J. 301:1992;80-83.
21. Mayer E.J., Newman B., Quesenberry C.P., Friedman G.D., Selby J.V. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 88:1993;2190-2197.
22. Facchini F., Chen Y.D.I., Reaven G.M. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 17:1994;115-119.
23. Kiechl S., Willeit J., Poewe W., Egger G., Oberhollenzer F., Muggeo M., Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Br. Med. J. 313:1996;1040-1044.
24. Rimm E.B., Chan J., Stampfer M.J., Colditz G.A., Willett W.C. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Br. Med. J. 310:1995;555-559.
25. de Zwart WM, Alcohol, tabak, drugs en gokken in cijfers. Utrecht: NIAD, 1993.
26. Kemm J. Alcohol and heart disease: the implications of the U-shaped curve. Br. Med. J. 307:1993;1373-1374.
27. Franz M.J., Horton E.S., Bantle J.P., Beebe C.A., Brunzell J.D., Coulston A.M., Henry R.R., Hoogwerf B.J., Stacpoole B.W. Nutritional principles for the management of diabetes and related complications. Diabetes Care. 17:1994;490-518.
28. Bell D.S.H. Alcohol and the NIDDM patient. Diabetes Care. 19:1996;509-513.